Posted on 20/12/05
Pfizer win in Lipitor challenge spurs drug stock rally
Pfizer Inc. led a rally of drug stocks yesterday after a U.S. court upheld the validity of patents on its best-selling Lipitor cholesterol drug against a challenge from India's leading generic company, Ranbaxy Laboratories Ltd.
The full text of this article has 503 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
